Person of the Month

Damian Carr is Founder and Educator at Eyedea MedTech Education, specialising in MedTech catheter design, innovation education and practical, industry-led learning. His work focuses on equipping engineers and teams with the hands-on knowledge needed to accelerate medical device development from initial concept through testing and refinement. Based in the West of Ireland, Damian has developed a strong, long-standing collaboration with the Medical and Engineering Technologies Technology Gateway at Atlantic Technological University. Through collaborative research and development, including work involving the Medical Imaging Suite, he has helped bring together industry-led design expertise with testing and clinical simulation capabilities to support faster and more responsive product development. Damian’s work reflects the importance of collaboration between industry, applied research and technology gateway expertise in advancing Ireland’s MedTech ecosystem, with a particular focus on sharing practical knowledge and supporting the development of new medical technologies.

Paul McCabe Named BioPharma & LifeSciences Connected Person of the Month for August 2026 APC & VLE Therapeutics Group Chief Operating Officer recognised for leadership, industry contribution and his work supporting the growth of Ireland’s indigenous biopharma sector Paul McCabe, Group Chief Operating Officer and Board Member at APC & VLE Therapeutics, has been recognised as the BioPharma & LifeSciences Connected Person of the Month for August 2026. Paul was presented with the award by Colin Murphy of Ingenious Media in recognition of his leadership within APC & VLE Therapeutics, his extensive contribution to Ireland’s life sciences industry and, in particular, his work with Ibec BPCI to develop a strategy to support a stronger indigenous biopharma sector in Ireland. With more than 35 years’ experience across the life sciences sector, Paul has worked across biotechnology, active pharmaceutical ingredients, vaccines, aseptic drug product, packaging and inspection, device and combination products and CMO operations, alongside significant operational, capital and strategic leadership responsibilities. After 30 years in Multinationals, Paul decided to take the leap in the indigenous SME sector and was responsible for establishing VLE Therapeutics in 2021 as a science-led GMP manufacturing company focused on clinical-phase therapies. VLE operates through an integrated model with APC, its sister company, combining pharmaceutical process development, digital capabilities and GMP clinical manufacturing to accelerate the development of medicines for patients. In January 2026, Paul became Group Chief Operating Officer and Board Member of APC & VLE Therapeutics, taking on responsibility for helping to deliver the group’s strategic growth ambitions across process development, digital innovation and science-led GMP clinical manufacturing. His contribution extends beyond his commercial role. Paul has been actively involved with Ibec BioPharmaChem Ireland (BPCI) and as a BPCI Board member, has led the development and promotion of its indigenous biopharma strategy, Together, for Others. The strategy is focused on strengthening Ireland’s indigenous BioPharmaChem ecosystem, supporting SMEs to scale, encouraging innovation and developing areas of the national life sciences value chain including academic commercialisation, early clinical-phase research and development, clinical trials, regulation and market access. COLIN MURPHY, INGENIOUS MEDIA “Paul has spent decades contributing to Ireland’s life sciences sector, but what particularly stands out is that he is still looking ahead at where Ireland can do more. His work with APC & VLE Therapeutics is part of an important story around growing our indigenous capability alongside the multinational base Ireland has built so successfully. “Paul also gives his own time and experience to the wider industry through Ibec BioPharmaChem Ireland and the Together, for Others Indigenous sector strategy. That combination of leadership within his own organisation and genuine commitment to the wider sector is exactly what this recognition is about. It was a real pleasure to present Paul with the award and congratulate him personally on a very well-deserved recognition.” PAUL MCCABE, APC & VLE THERAPEUTICS “I am honoured to receive this award and sincerely thank Colin & the team for the recognition. Working in the Life Sciences sector is really rewarding as we get to work at the cutting edge of science and develop medicines to improve patient’s lives. The future of Ireland’s indigenous biopharma sector is incredibly exciting, and I look forward to continuing to work with colleagues across the industry to help realise its full potential and ensure a sustainable future for Ireland’s BioPharma sector.” The BioPharma & LifeSciences Connected Person of the Month programme recognises individuals whose leadership, innovation and contribution are helping to advance Ireland’s biopharma and life sciences community. Congratula

Evumed President Colm Moynihan Recognised as BioPharma & LifeSciences Connected Person of the Month for July 2026. Experienced pharmaceutical leader recognised as Evumed builds its European operations from Cork Colm Moynihan, President of Evumed Limited, has been presented with the BioPharma & LifeSciences Connected Person of the Month award for July 2026, recognising his leadership and contribution to Ireland’s pharmaceutical and life sciences sector. The award was presented by Colin Murphy of Ingenious Media during a visit to Evumed in Cork. Colm brings more than 26 years of experience in global operations across the pharmaceutical and food sectors, with a career spanning finance, operations, supply chain, regulatory oversight, quality, international partnerships and business leadership. He has served as President of Evumed since July 2025. Before joining Evumed, Colm spent almost 17 years with NorthStar Healthcare and McKesson, progressing through senior finance and management positions to Vice President, General Manager and Board Member, with responsibility for overseas operations including quality, regulatory, supply chain and global logistics. His recognition comes at an important stage in Evumed’s development. The company has officially opened its European headquarters at Cork Airport Business Park as it expands its presence across Europe. Evumed plans to create 32 new roles across commercial, regulatory, quality, finance, HR and administrative functions. Established in 2025, Evumed specialises in generic injectables, branded medicines and biosimilars. The company is building its European operations from Cork, supported by a strong product portfolio and global partnerships, with a focus on improving access to affordable medicines. Commenting on the recognition, Colm Moynihan said: “I am honoured to receive this recognition. While presented to an individual, it reflects the dedication and ambition of the entire Evumed team as we continue growing our European business from Cork. This has been an exciting period for Evumed, and we are grateful for the support we have received. I would like to thank IDA Ireland for helping us establish our European headquarters at Cork Airport Business Park and supporting our growth ambitions. I would also like to acknowledge the Cork life sciences community for its collaboration, innovation and openness. Evumed has benefited greatly from the support and expertise available within this strong ecosystem. We are excited about the future and remain committed to expanding access to medicines across Europe while contributing to the continued success of the life sciences sector in Cork and Ireland.” Colin Murphy of Ingenious Media said: “Colm’s recognition is very well deserved. It was a real pleasure to visit Evumed, present the award and hear more about what the team is building from Cork. There is a lot of ambition behind the business, but what also stood out was Colm’s appreciation for the support around them, particularly IDA Ireland and the Cork life sciences community. That kind of collaboration is one of the great strengths of the sector here. Thank you to Colm and the team for such a warm welcome. I’m looking forward to seeing where they take Evumed next.” The BioPharma & LifeSciences Connected Person of the Month programme recognises individuals whose leadership, innovation and contribution are helping to advance Ireland’s biopharma and life sciences community. Colm will be recognised again at the annual BioPharma & LifeSciences Connected Awards, taking place at the Radisson Blu, Little Island, Cork on 28th January 2027. The overall BioPharma & LifeSciences Connected Person of the Year will be selected from the 2026 monthly recipients. Congratulations to Colm Moynihan on a very well-deserved recognition.

Tim Jones is CEO and Co-Founder of SymPhysis Medical and a member of the MedLink Galway Steering Committee. With more than 25 years of industry experience, including 15 years in medtech, he has built his career around developing new technologies, building companies and working closely with clinical and industry partners to address real healthcare needs. A BioInnovate Ireland alumnus, Tim co-founded SymPhysis Medical with Dr Michelle Tierney in 2018, establishing the company around a needs-led approach to innovation and close collaboration with clinicians. Headquartered in Galway, SymPhysis Medical has since raised €12 million, secured granted patents across 15 territories and established Irish manufacturing through Phillips-Medisize in Letterkenny, while progressing plans for the US market. Alongside his work with SymPhysis Medical, Tim contributes to the wider medtech ecosystem through MedLink Galway, supporting collaboration between industry, clinicians, researchers and the innovation community.

Ronan MacLoughlin, PhD MBS, Director of Emerging Technologies and Director of Business Development at Aerogen Limited Person of the Month: June 2026 Ronan MacLoughlin, PhD MBS, Director of Emerging Technologies and Director of Business Development at Aerogen Limited, has been named the MedTech Innovation Person of the Month for June 2026. Ronan received the award at Aerogen on Monday, 6th July, presented by Dr Jamie Meehan on behalf of MedTech Innovation. Throughout his career at Aerogen, Ronan has combined scientific and technical expertise with a strong commercial understanding of the medtech industry. His work has contributed to the advancement of innovative technologies while supporting the partnerships and research relationships that help move new ideas from development towards real-world application. The recognition also reflects Ronan’s long-standing relationship with the Medical and Engineering Technologies Gateway at Atlantic Technological University. Through collaborative research and development projects, Aerogen and MET have demonstrated the important role that cooperation between industry and research organisations can play in supporting innovation, strengthening technical capabilities and delivering meaningful outcomes for the medtech sector. Accepting the recognition, Ronan highlighted the value of this collaboration: “MET has been a vital part of that ecosystem in Ireland, and very impactful here in the west, with some significant local wins on the books. I am delighted to have been able to support since the beginning.” Ronan’s willingness to support collaborative research, share industry insight and engage with Ireland’s wider medtech community has made him a respected contributor to the sector. His work reflects the combination of leadership, innovation and industry-research cooperation that continues to strengthen Ireland’s international reputation in medical technology.

RINN Pharma & Biopharma COO Sarah Hayes recognised for strengthening collaboration across Ireland's life sciences sector. Sarah Hayes is Chief Operating Officer at Rinn Pharma & Biopharma, where she focuses on strengthening collaboration between research, academia, industry and wider societal stakeholders. With more than a decade of experience across operations, public engagement, education and academic partnerships, Sarah has played a key role in supporting Ireland’s pharmaceutical and biopharmaceutical research ecosystem. Her work helps connect scientific excellence with industry needs, building partnerships that advance innovation and deliver meaningful national and international impact. Sarah was named Biopharma & Lifesciences Connected Person of the Month for June 2026 in recognition of her leadership and contribution to Ireland’s life sciences sector.

Poolbeg Pharma CEO Jeremy Skillington recognised as Irish biotech sector gains momentum. Jeremy Skillington, PhD, Chief Executive Officer of Poolbeg Pharma plc, has been named Biopharma & Life Sciences Connected Person of the Month for May 2026. The recognition acknowledges Skillington’s leadership of Poolbeg Pharma and his wider contribution to the development of Ireland’s biotechnology sector. Ireland is internationally established as a centre for pharmaceutical and biopharmaceutical manufacturing. Alongside that strength, a growing group of Irish-founded companies are developing medicines, intellectual property and commercial capability from Ireland, broadening the country’s role within the global life sciences industry. Poolbeg Pharma is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field. The company’s lead programme, POLB 001, has the potential to expand administration of cancer immunotherapies from centralised specialist cancer centres into community hospitals by making treatments safer through the prevention of the life-threatening side effect, Cytokine Release Syndrome (CRS). As such, POLB 001 could increase the number of patients that receive these life-saving treatments. Poolbeg is also developing an oral encapsulated GLP-1, a patient-friendly therapy for obesity, offering a differentiated approach in one of the world’s largest markets. Prior to Poolbeg, Jeremy was instrumental in the acquisition of Irish biotech company Inflazome by Roche in 2020 for €380M upfront and downstream development milestones. In addition Jeremy was member of the Indigenous Steering Committee for the “Together, for Others – A Strategy for Ireland’s BioPharmaChem Indigenous Ecosystem” recently launched by BioPharmaChem Ireland and sits on the Advisory Committee for the ARC Hub for Therapeutics. He is an Adjunct Assistant Professor at Trinity College Dublin lecturing in Bioentrepreneurship. Skillington has worked across the biotechnology sector for more than two decades. His career has included roles at Genentech, Opsona Therapeutics, TriMod Therapeutics, HS Lifesciences and Inflazome. He has served as Chief Executive Officer of Poolbeg Pharma since 2021. Jeremy Skillington, PhD, Chief Executive Officer of Poolbeg Pharma plc, said: “I am honoured to be recognised with this award for my contributions to Irish biotech sector. We’re at an exciting stage in our Poolbeg journey advancing POLB 001 towards what we believe could be a transformative treatment for cancer immunotherapy patients, and progress like this is only possible because of the talented teams and collaborators we work alongside. Ireland has built a genuinely world-class life science ecosystem, and it’s a privilege to be a part of its continued growth.” Under Skillington’s leadership, Poolbeg Pharma has continued to advance its development programmes while building its profile with investors, research partners and the wider international life sciences community. The company’s progress also reflects the work of a wider team spanning scientific development, finance, investor relations and communications. As a publicly listed company, Poolbeg Pharma’s ability to communicate scientific and commercial progress clearly is central to maintaining engagement with investors, partners and the market. Colin Murphy, Founder and Chairman of Ingenious Media, said Skillington’s recognition reflected the increasing confidence and ambition within Ireland’s home-grown life sciences sector. “Jeremy has built a career at the point where science, company development and commercial opportunity meet. His leadership at Poolbeg Pharma reflects the ambition we are seeing across Irish-founded life sciences companies and the growing role they can play in international drug development. “We are delighted to recognise Jeremy as Person of the Month for May 2026 and look forward to welcoming him, together with the other monthly recipients, to Cork in January.

Lisa Lynch, Senior R&D Manager at Boston Scientific, has been named MedTech Innovation Person of the Month for May 2026. Based in Galway, Lynch has played a key role in advancing research and development activity within Boston Scientific, while also contributing to wider collaboration across the Irish medtech ecosystem. Her work reflects a broader shift within the sector, where partnerships between industry and research centres are helping accelerate innovation and product development.  This momentous celebration is proudly supported by our innovative core event partners at https://www.medtechinnovation.ie/ . Ingenious Media and the Enterprise Ireland-funded Medical and Engineering Technologies (MET) Gateway at ATU, working together to bridge the gap between world-class research and commercial industrial applications.  Jamie Meehan, Technology Gateway Manager at MET, said:  “ Lisa’s recognition reflects the strength of collaboration that exists within the Irish medtech sector. The ability to bring together industry expertise and applied research is a key factor in how innovation is being delivered at pace .”  Lisa Lynch, Senior R&D Manager at Boston Scientific, said:  “ As an engineer, I benefit from the MET as it bridges the gap between product engineering and clinical application, effectively bringing complex medical data into actionable engineering insights that help inform product development ”

Cork life sciences leader recognised as Ireland’s biopharma sector continues to move up the value chain. Edel Collins, General Manager at Thermo Fisher Scientific’s Cork site, has been named Person of the Month for April 2026 as part of the Biopharma & Life Sciences Connected recognition series. The recognition comes at a time when Ireland’s life sciences sector is being asked to deliver more than manufacturing capacity alone. Across pharma, biopharma and medtech, Irish sites are playing a greater role in advanced production, technical capability, supply chain resilience and long-term global operations. Collins leads Thermo Fisher Scientific’s – API development and manufacturing operation in Cork, one of the country’s long-established pharma services sites. Her selection recognises her leadership within a sector where site-level expertise, team development and operational consistency are increasingly central to Ireland’s international reputation. The Cork site, which marked 50 years in operation last year, reflects the depth of experience that has helped Ireland remain a trusted location for global life sciences activity. Its continued role within Thermo Fisher Scientific’s network also highlights the importance of regional sites in supporting complex pharmaceutical supply chains. Edel Collins, General Manager at Thermo Fisher Scientific, said: “It’s an exciting time for the CDMO sector in Ireland – we’re seeing incredible momentum, innovation, and global impact. I’m honoured to receive this award and proud to be part of an industry that is not only advancing science but also strengthening Ireland’s position as a leading hub for biopharmaceutical development and manufacturing. ” Colin Murphy, Founder and Chairman of Ingenious Media, said: “Edel’s recognition is about more than one individual achievement. It reflects the calibre of leadership that exists across Ireland’s life sciences sector. Sites like Cork are central to the industry’s strength, and the people leading them deserve to be recognised for the role they play in sustaining that progress.” The Person of the Month initiative highlights individuals making a meaningful contribution across biopharma, medtech and life sciences in Ireland. Each monthly recipient will be recognised as part of the wider Biopharma & Life Sciences Connected programme, with a Person of the Year to be selected from the 2026 recipients. The award will be presented to Edel Collins at a forthcoming ceremony.

Tom Quinn, Vice President and Site Head, Novo Nordisk Production Ireland, Athlone named inaugural Biopharma & Life Sciences Connected Person of the Month Biopharma & Life Sciences Connected is pleased to announce Tom Quinn, Vice President and Site Head of Novo Nordisk Production Ireland, Athlone, as the inaugural recipient of its new Person of the Month recognition programme. The initiative has been established to honour outstanding professionals whose work is shaping the biopharma and life sciences community. Long called for by the sector, these awards are designed to provide a prestigious and credible platform for recognising excellence, leadership and achievement, and we are proud to now bring them to life through Biopharma & Life Sciences Connected. Tom Quinn has been selected as the first recipient in recognition of the significant and positive developments at Novo Nordisk’s Athlone facility and the wider impact of that strategic achievement for the industry in Ireland, particularly across the Midlands region. Biopharma & Life Sciences Connected has, over the past seven years, built a strong reputation as a respected platform within the sector, bringing together senior professionals from across industry, academia, government bodies, and key stakeholder organisations. The launch of these awards marks a natural next step in recognising the individuals whose leadership, commitment and achievements are helping to shape the future of the biopharma and life sciences community. The Person of the Month winners will be selected by an independent judging committee chaired by Matt Moran and Barry Kennedy. Colin Murphy, Chairman and Founder of Ingenious Media, said: “We are delighted to recognise Tom Quinn as the inaugural Biopharma & Life Sciences Connected Person of the Month. Tom’s leadership and the significant progress and investment taking place in Athlone reflect the calibre of achievement these awards are intended to celebrate. His recognition also speaks to the strength of the team he leads, the endorsement of Ireland as a strategic hub for biopharma, and the wider impact of Novo Nordisk Production Ireland within Ireland’s biopharma and life sciences community.” On receiving the award, Tom Quinn, VP and Site Head, Novo Nordisk Production Ireland, Athlone said: Being named the inaugural Biopharma & Life Sciences Connected Person of the Month is a tremendous honour, reflecting the collective effort of our exceptional team in Athlone and underscores Novo Nordisk’s long-term commitment to Ireland and global healthcare innovation. As the global leader in obesity and diabetes care, Novo Nordisk delivers life-changing treatments for patients worldwide. We are proud to play our part to continue to advance and further strengthen the Midlands and Ireland’s Life Sciences ecosystem. I would like to thank Biopharma & Life Sciences Connected for this award and I am grateful to be part of a team and an industry that continues to improve outcomes for patients and strengthens Ireland’s biopharma community. I also want to recognise the fantastic support by the IDA, Government, local County Councils and the Technological University of the Shannon in enabling the recent significant investment” The Person of the Month programme will culminate in a special awards evening in January 2027, where all the 2026 recipients will be invited as VIP guests and the overall Biopharma & Life Sciences Connected Person of the Year will be announced. The event will mark the formal launch of what is set to become a prestigious annual recognition for outstanding professionals across Ireland’s biopharma and life sciences communities.